Barclays initiated coverage of GE HealthCare (GEHC) with an Equal Weight rating and $86 price target The company continues to lead the market in artificial intelligence-enabled medical devices, the analyst tells investors in a research note. However, the firm expects GE HealthCare will see “sluggish” growth in China in the near-term, which will temper expectations into 2026.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GEHC:
- IBM partners with Anthropic, Dell boosts long-term view: Morning Buzz
- Netflix upgraded, Dollar Tree downgraded: Wall Street’s top analyst calls
- GE HealthCare downgraded to Neutral from Buy at Citi
- Lantheus rallies after inking GE licensing agreement for Japan
- Nvidia to invest $5B in Intel, ABC pulls ‘Jimmy Kimmel Live!’: Morning Buzz